Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Current Assets (2013 - 2026)

Scynexis' (SCYX) quarterly Current Assets came in at $56.2 million in Q2 2026, little changed on a YoY basis from $56.5 million in Q2 2025, and down 10.3% quarter-over-quarter from $62.7 million in Q1 2026.

Analysis

Scynexis (SCYX) Current Assets (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Current Assets for 14 consecutive years, with $56.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Assets changed 0.46% year-over-year to $56.2 million; the trailing twelve-month figure through Jun 2026 stood at $56.2 million (changed 0.46% YoY), and the FY2025 full-year result was $40.4 million, down 44.07% from the prior year.
  • Current Assets slipped to $56.2 million in Q2 2026 per SCYX's latest filing, from $62.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $145.5 million in Q2 2023 and bottomed at $40.4 million in Q4 2025.
  • Historically, Current Assets has averaged $84.0 million across 5 years, with a median of $79.8 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Current Assets surged 70.12% in 2024, then slumped 48.64% in 2025.
  • Over 5 years, Current Assets stood at $79.1 million in 2022, then gained by 29.16% to $102.1 million in 2023, then slipped by 29.31% to $72.2 million in 2024, then plunged by 44.07% to $40.4 million in 2025, then soared by 39.29% to $56.2 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $56.2 million, $62.7 million, and $40.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 8.07 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 4.74 Bn
10 Scynexis 58.41 Mn -56.29 Mn - 56.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.24 Mn
Mar 31, 2026 62.69 Mn
Dec 31, 2025 40.37 Mn
Sep 30, 2025 48.69 Mn
Jun 30, 2025 56.50 Mn
Mar 31, 2025 52.22 Mn
Dec 31, 2024 72.18 Mn
Sep 30, 2024 80.46 Mn
Jun 30, 2024 94.58 Mn
Mar 31, 2024 101.67 Mn
Dec 31, 2023 102.12 Mn
Sep 30, 2023 128.64 Mn
Jun 30, 2023 145.53 Mn
Mar 31, 2023 59.77 Mn
Dec 31, 2022 79.06 Mn
Sep 30, 2022 103.57 Mn
Jun 30, 2022 125.68 Mn
Mar 31, 2022 101.91 Mn
Dec 31, 2021 109.38 Mn
Sep 30, 2021 103.93 Mn